Inside the first wave of speakers confirmed for Women’s Health Week USA 2026

The first wave of speakers for Women’s Health Week USA 2026 has been announced, setting the direction for the conversations taking place at the New York Academy of Medicine on May 13 to 14.
This early look at the lineup brings together pioneering industry leaders actively shaping how women’s health is funded and scaled.
From global policy and regulation to venture capital, healthcare delivery, and technology, these speakers reflect a sector that has moved beyond momentum into execution.
Organisations represented include Samsung Next, the FDA, the National Institutes of Health, WHO, CVS Health Ventures, ARPA-H, Clue, Kindbody, and Natural Cycles, signalling the growing institutional focus on women’s health as critical healthcare infrastructure.
Among the first speakers announced:
- Mallika Mundkur, Deputy Chief Medical Officer, FDA
- Jonathan Machado, Managing Director, Samsung Next
- Elina Berglund Scherwitzl, CEO, Natural Cycles
- David Stern, CEO, Kindbody
- Elizabeth Bailey, Managing Partner, Foreground Capital
- Rep Sara Jacobs, Congresswoman, California’s 51st Congressional District
Women’s Health Week USA is built around partnership, with a program focused on the practical realities of scale: capital deployment, regulatory pathways, clinical adoption, and distribution.
This first speaker wave sets the tone for an agenda designed to turn insight into action.
View the full speaker lineup and explore the first release of the 2026 programme as more sessions and speakers are announced.
More to come.
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.










